Coffee consumption and the occurrence and intensity of metabolic syndrome: a cross-sectional study

International Journal of Food Sciences and Nutrition

Volumn 68, Issue 4, 2017, Pages 507-513

  Suliga, Edyta ^a   Kozieł, Dorota ^a   Cieśla, Elżbieta ^a   Rębak, Dorota ^a   Głuszek, Stanisław ^a  

^a JAN KOCHANOWSKI UNIVERSITY   (Poland)

Author keywords

BMI; Coffee consumption; metabolic syndrome

Indexed keywords

ADULT; COFFEE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; OBESITY; ODDS RATIO;

ADULT; COFFEE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME; MIDDLE AGED; ODDS RATIO; OVERWEIGHT;

EID: 84995538652     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.1080/09637486.2016.1256381     Document Type: Article

References (38)

1. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC, Jr, et al. 2009. Harmonizing the metabolic syndrome:a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 120:1640–1645.
2. Allam-Ndoul B, Guenard F, Garneau V, Cormier H, Barbier O, Perusse L, Vohl MC., 2016. Association between metabolite profiles, metabolic syndrome and obesity status. Nutrients. 8:324. doi:10.3390/nu8060324.
3. Balk L, Hoekstra T, Twisk J., 2009. Relationship between long-term coffee consumption and components of the metabolic syndrome:the Amsterdam Growth and Health Longitudinal Study. Eur J Epidemiol. 24:203–209.
4. Dehghan M, Ilow R, Zatonska K, Szuba A, Zhang X, Mente A, Regulska-Ilow B., 2012. Development, reproducibility and validity of the food frequency questionnaire in the Poland arm of the Prospective Urban and Rural Epidemiological (PURE) study. J Hum Nutr Diet. 25:225–232.
5. Ding M, Bhupathiraju SN, Chen M, van Dam RM, Hu FB., 2014a. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes:a systematic review and a dose-response meta-analysis. Diabetes Care. 37:569–586.
6. Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB., 2014b. Long-term coffee consumption and risk of cardiovascular disease:a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation. 129:643–659.
7. Ding M, Satija A, Bhupathiraju SN, Hu Y, Sun Q, Han J, Lopez-Garcia E, Willett W, van Dam RM, Hu FB., 2015. Association of coffee consumption with total and cause-specific mortality in 3 large prospective cohorts. Circulation. 132:2305–2315.
8. Driessen MT, Koppes LL, Veldhuis L, Samoocha D, Twisk JW., 2009. Coffee consumption is not related to the metabolic syndrome at the age of 36 years:the Amsterdam Growth and Health Longitudinal Study. Eur J Clin Nutr. 63:536–542.
9. Gavrieli A, Karfopoulou E, Kardatou E, Spyreli E, Fragopoulou E, Mantzoros CS, Yannakoulia M., 2013. Effect of different amounts of coffee on dietary intake and appetite of normal-weight and overweight/obese individuals. Obesity (Silver Spring). 21:1127–1132.
10. Greenberg JA, Axen KV, Schnoll R, Boozer CN., 2005. Coffee, tea and diabetes:the role of weight loss and caffeine. Int J Obes (Lond). 29:1121–1129.
11. Grosso G, Marventano S, Galvano F, Pajak A, Mistretta A., 2014. Factors associated with metabolic syndrome in a Mediterranean population:role of caffeinated beverages. J Epidemiol. 24:327–333.
12. Grosso G, Stepaniak U, Micek A, Topor-Madry R, Pikhart H, Szafraniec K, Pajak A., 2015. Association of daily coffee and tea consumption and metabolic syndrome:results from the Polish arm of the HAPIEE study. Eur J Nutr. 54:1129–1137.
13. Hedstrom AK, Mowry EM, Gianfrancesco MA, Shao X, Schaefer CA, Shen L, Olsson T, Barcellos LF, Alfredsson L., 2016. High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies. J Neurol Neurosurg Psychiatry. 87:454–460.
14. Hino A, Adachi H, Enomoto M, Furuki K, Shigetoh Y, Ohtsuka M, Kumagae S, Hirai Y, Jalaldin A, Satoh A, et al. 2007. Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome:an epidemiological study in a general Japanese population. Diabetes Res Clin Pract. 76:383–389.
15. Jee SH, He J, Whelton PK, Suh I, Klag MJ., 1999. The effect of chronic coffee drinking on blood pressure:a meta-analysis of controlled clinical trials. Hypertension. 33:647–652.
16. Jiang X, Zhang D, Jiang W., 2014. Coffee and caffeine intake and incidence of type 2 diabetes mellitus:a meta-analysis of prospective studies. Eur J Nutr. 53:25–38.
17. Lee AH, Tan L, Hiramatsu N, Ishisaka A, Alfonso H, Tanaka A, Uemura N, Fujiwara Y, Takechi R., 2016. Plasma concentrations of coffee polyphenols and plasma biomarkers of diabetes risk in healthy Japanese women. Nutr Diabetes. 6:e212. doi:10.1038/nutd.2016.19.
18. Lutsey PL, Steffen LM, Stevens J., 2008. Dietary intake and the development of the metabolic syndrome:the Atherosclerosis Risk in Communities study. Circulation. 117:754–761.
19. Marventano S, Salomone F, Godos J, Pluchinotta F, Del Rio D, Mistretta A, Grosso G., 2016. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome:a systematic review and meta-analysis of observational studies. Clin Nutr. 35:1269–1281.
20. Matsuura H, Mure K, Nishio N, Kitano N, Nagai N, Takeshita T., 2012. Relationship between coffee consumption and prevalence of metabolic syndrome among Japanese civil servants. J Epidemiol. 22:160–166.
21. Meng S, Cao J, Feng Q, Peng J, Hu Y., 2013. Roles of chlorogenic acid on regulating glucose and lipids metabolism:a review. Evid Based Complement Alternat Med. 2013:801457. doi:10.1155/2013/801457.
22. Neary MT, Batterham RL., 2009. Gut hormones:implications for the treatment of obesity. Pharmacol Ther. 124:44–56.
23. Nordestgaard AT, Thomsen M, Nordestgaard BG., 2015. Coffee intake and risk of obesity, metabolic syndrome and type 2 diabetes:a Mendelian randomization study. Int J Epidemiol. 44:551–565.
24. O'Keefe JH, Bhatti SK, Patil HR, DiNicolantonio JJ, Lucan SC, Lavie CJ., 2013. Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. J Am Coll Cardiol. 62:1043–1051.
25. Pimentel VR, de Sousa MF, Hamann EM, Mendonca AV., 2014. Food and nutrition in the family health strategy in five Brazilian cities. Cien Saude Colet. 19:49–57.
26. Qi H, Li S., 2014. Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease. Geriatr Gerontol Int. 14:430–439.
27. Ran HQ, Wang JZ, Sun CQ., 2016. Coffee consumption and pancreatic cancer risk:an update meta-analysis of cohort studies. Pak J Med Sci. 32:253–259.
28. Reaven G, Abbasi F, McLaughlin T., 2004. Obesity, insulin resistance, and cardiovascular disease. Recent Prog Horm Res. 59:207–223.
29. Saleh D, Janssen I., 2014. Interrelationships among sedentary time, sleep duration, and the metabolic syndrome in adults. BMC Public Health. 14:666. doi:10.1186/1471-2458-14-666.
30. Schmit SL, Rennert HS, Rennert G, Gruber SB., 2016. Coffee consumption and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 25:634–639.
31. Setiawan VW, Wilkens LR, Lu SC, Hernandez BY, Le Marchand L, Henderson BE., 2015. Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort. Gastroenterology. 148:118–125; quiz e115.
32. Shang F, Li X, Jiang X., 2016. Coffee consumption and risk of the metabolic syndrome:a meta-analysis. Diabetes Metab. 42:80–87.
33. Suliga E, Koziel D, Ciesla E, Gluszek S., 2015. Association between dietary patterns and metabolic syndrome in individuals with normal weight:a cross-sectional study. Nutr J. 14:55. doi:10.1186/s12937-015-0045-9.
34. Takami H, Nakamoto M, Uemura H, Katsuura S, Yamaguchi M, Hiyoshi M, Sawachika F, Juta T, Arisawa K., 2013. Inverse correlation between coffee consumption and prevalence of metabolic syndrome:baseline survey of the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study in Tokushima, Japan. J Epidemiol. 23:12–20.
35. Wilson PW, Bloom HL., 2016. Caffeine consumption and cardiovascular risks:little cause for concern. J Am Heart Assoc. 5:e003089. doi:10.1161/JAHA.115.003089.
36. Zak-Golab A, Kocelak P, Aptekorz M, Zientara M, Juszczyk L, Martirosian G, Chudek J, Olszanecka-Glinianowicz M., 2013. Gut microbiota, microinflammation, metabolic profile, and zonulin concentration in obese and normal weight subjects. Int J Endocrinol. 2013:674106. doi:10.1155/2013/674106.
37. Zamora-Ros R, Forouhi NG, Sharp SJ, Gonzalez CA, Buijsse B, Guevara M, van der Schouw YT, Amiano P, Boeing H, Bredsdorff L, et al. 2014. Dietary intakes of individual flavanols and flavonols are inversely associated with incident type 2 diabetes in European populations. J Nutr. 144:335–343.
38. Zatonski WA, Manczuk M, Kielce Pt., 2011. POlish-Norwegian Study (PONS):research on chronic non-communicable diseases in European high risk countries–study design. Ann Agric Environ Med. 18:203–206.